| Literature DB >> 29856527 |
Seth J Rotz1, Russell E Ware2,3, Ashish Kumar2,4.
Abstract
Children, adolescents, and young adults with chronic refractory autoimmune cytopenias represent a rare but challenging group of patients, who are managed frequently by pediatric hematologists. Novel diagnostic tests and genomic discoveries are refining historical diagnoses of Evans syndrome and common variable immunodeficiency, while also elucidating the cellular and molecular basis for these disorders. Genetic characterization of chronic and refractory autoimmune cytopenias has led to targeted therapies with improved clinical outcomes and fewer off-target toxicities. In this review, we focus on the appropriate diagnostic workup, expanded genetic testing, and novel treatment opportunities that are available for these challenging patients.Entities:
Keywords: AIHA; CVID; Evans syndrome; ITP; alps; cytopenia; immunohematology
Mesh:
Year: 2018 PMID: 29856527 DOI: 10.1002/pbc.27260
Source DB: PubMed Journal: Pediatr Blood Cancer ISSN: 1545-5009 Impact factor: 3.167